title: Improving the outcome of septic shock in children.
abstract: Sepsis is an important cause of pediatric morbidity and mortality. Improving the outcome of pediatric sepsis requires diverse efforts, including prevention, early recognition, improvements in early management and transport, and physiology-directed care. Awareness that septic shock represents a pathophysiologic host response to infection has prompted investigation of immune mediators and coagulation factors as potential targets for anti-sepsis therapies. Advancements thus far include: the potential prevention of neonatal sepsis with granulocyte colony-stimulating factor; recognition of clindamycin as a potential inhibitor of endotoxin release; improved outcome from meningococcal disease in children treated with bactericidal/permeability-increasing protein (rBPI21); and improved outcome from sepsis in premature infants treated with pentoxifylline. Further randomized controlled studies of immunomodulatory agents are indicated and a few are in progress. Current studies on genetic propensities in cytokine and coagulation protein expression may explain variability in patient outcomes and eventually lead to genomics-based therapeutics.
authors.affiliation: aDepartment of Pediatrics,Wilford Hall Medical Center, Lackland AFB, Texas, USA and bDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
authors.forename: Erica A.
authors.initials: EA
authors.lastname: Kirsch
authors.forename: Brett P.
authors.initials: BP
authors.lastname: Giroir